Science Explorer Back to mapMap
Discussion
Company · Hørsholm · Denmark

Savara (Denmark)

Research works
3
▼ 91% vs 2018-21
Citations
57
18.4 per fractional work
Top-10% rate
45.8%
all institutions 10.0%
Open access
30%
world 40%
International
73%
world 18%

Not ranked overall: Savara (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Savara (Denmark) work in?

In all years, 52% of research at Savara (Denmark) is in Life Sciences, 45% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Medicine (42%), Immunology and Microbiology (6%). It does 1.3× the world's share of Life Sciences.

Life Sciences52%Physical Sciences3%Health Sciences45%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology145.2%
    2. Immunology and Microbiology06.5%
    1. Medicine141.9%
    2. Health Professions03.2%
    1. Chemistry03.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Savara (Denmark)?

The most cited paper from Savara (Denmark) is "Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis" (Bruce C. Trapnell, Yoshikazu Inoue, Francesco Bonella et al., 2020), with 120 citations. Next come "Monitoring process-related impurities in biologics–host cell protein analysis" (77) and "A novel approach to evaluate ELISA antibody coverage of host cell proteins—combining ELISA‐based immunocapture and mass spectrometry" (36).

Most cited papers
#PaperReleasedCitations
1 Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis Bruce C. Trapnell, Yoshikazu Inoue, Francesco Bonella et al. · New England Journal of Medicine Open access 7 Sep 2020 120
2 Monitoring process-related impurities in biologics–host cell protein analysis Katrine Pilely, Martin Rask Johansen, Rikke Raaen Lund et al. · Analytical and Bioanalytical Chemistry Open access Oct 2021 77
3 A novel approach to evaluate ELISA antibody coverage of host cell proteins—combining ELISA‐based immunocapture and mass spectrometry Katrine Pilely, Solveig Beck Nielsen, Anette Holck Draborg et al. · Biotechnology Progress Open access 22 Feb 2020 36
4 OPTIMA: An Open-Label, Noncomparative Pilot Trial of Inhaled Molgramostim in Pulmonary Nontuberculous Mycobacterial Infection Rachel Thomson, Michael R. Loebinger, Andrew Burke et al. · Annals of the American Thoracic Society 10 Nov 2023 20
5 BSTP Review of 12 Case Studies Discussing the Challenges, Pathology, Immunogenicity, and Mechanisms of Inhaled Biologics Peter Hall et al. · Toxicologic Pathology Open access 18 Jan 2021 17
All 8 most cited papers, with filters and sorting

Which research topics does Savara (Denmark) publish most on?

By volume in 2022-now: Microwave-Assisted Synthesis and Applications, Pulmonary Hypertension Research and Treatments, Neonatal Respiratory Health Research and Medical Imaging and Pathology Studies.

  1. 1 Microwave-Assisted Synthesis and Applications Organic Chemistry 0 works
  2. 2 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
  3. 3 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 0 works
  4. 4 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 0 works
  5. 5 Mycobacterium research and diagnosis Epidemiology 0 works
  6. 6 Tuberculosis Research and Epidemiology Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.3%not open69.7%

World: 40% of research is openly available.

with international co-authors73.0%domestic only27.0%

World: 18% is written across borders.

How has Savara (Denmark)'s research output changed?

Output in 2022-2025 was 91% lower than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Hørsholm

All research institutions in Hørsholm

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Savara (Denmark). Posts are plain text and can be reported.